Phase I/II study of the PARP inhibitor olaparib in combination with irinotecan in children with advanced malignancies: arm D of the AcSe-ESMART trial
Susanne A. Gatz,Pablo Berlanga, Baptiste Archambaud,Yassine Bouchoucha,Nicolas Andre,Nadege Corradini,Windy Rondof,Jonathan Rubino,Souad Nebchi,Antonin Marchais,Estelle Thebaud, Alba Rubio San Simon,Natasha K. van Eijkelenburg,Lynley V. Marshall,Anne-Sophie Defachelles, Adela Canyete,Stephane Ducassou,Guy Makin,Michela Casanova,Emilie De Carli,Arnaud Petit,Gwenael Le Teuff,Xavier Paoletti, Peter G. Mortimer,Gilles Vassal,Birgit Geoerger CANCER RESEARCH（2023）
AI 理解论文
溯源树
样例
